ICUI Relative Valuation
ICUI's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ICUI is overvalued; if below, it's undervalued.
Historical Valuation
ICU Medical Inc (ICUI) is now in the Undervalued zone, suggesting that its current forward PS ratio of 1.58 is considered Undervalued compared with the five-year average of -19.66. The fair price of ICU Medical Inc (ICUI) is between 217.13 to 331.34 according to relative valuation methord. Compared to the current price of 150.32 USD , ICU Medical Inc is Undervalued By 30.77%.
Relative Value
Fair Zone
217.13-331.34
Current Price：150.32
30.77%
Undervalued
173.53
PE
1Y
3Y
5Y
11.26
EV/EBITDA
ICU Medical Inc. (ICUI) has a current EV/EBITDA of 11.26. The 5-year average EV/EBITDA is 13.05. The thresholds are as follows: Strongly Undervalued below 9.46, Undervalued between 9.46 and 11.25, Fairly Valued between 14.85 and 11.25, Overvalued between 14.85 and 16.65, and Strongly Overvalued above 16.65. The current Forward EV/EBITDA of 11.26 falls within the Historic Trend Line -Fairly Valued range.
14.03
EV/EBIT
ICU Medical Inc. (ICUI) has a current EV/EBIT of 14.03. The 5-year average EV/EBIT is 18.34. The thresholds are as follows: Strongly Undervalued below 10.13, Undervalued between 10.13 and 14.24, Fairly Valued between 22.45 and 14.24, Overvalued between 22.45 and 26.56, and Strongly Overvalued above 26.56. The current Forward EV/EBIT of 14.03 falls within the Undervalued range.
1.58
PS
ICU Medical Inc. (ICUI) has a current PS of 1.58. The 5-year average PS is 1.90. The thresholds are as follows: Strongly Undervalued below 0.41, Undervalued between 0.41 and 1.16, Fairly Valued between 2.65 and 1.16, Overvalued between 2.65 and 3.40, and Strongly Overvalued above 3.40. The current Forward PS of 1.58 falls within the Historic Trend Line -Fairly Valued range.
12.20
P/OCF
ICU Medical Inc. (ICUI) has a current P/OCF of 12.20. The 5-year average P/OCF is 19.75. The thresholds are as follows: Strongly Undervalued below -10.11, Undervalued between -10.11 and 4.82, Fairly Valued between 34.69 and 4.82, Overvalued between 34.69 and 49.62, and Strongly Overvalued above 49.62. The current Forward P/OCF of 12.20 falls within the Historic Trend Line -Fairly Valued range.
17.65
P/FCF
ICU Medical Inc. (ICUI) has a current P/FCF of 17.65. The 5-year average P/FCF is 21.79. The thresholds are as follows: Strongly Undervalued below -15.24, Undervalued between -15.24 and 3.28, Fairly Valued between 40.30 and 3.28, Overvalued between 40.30 and 58.82, and Strongly Overvalued above 58.82. The current Forward P/FCF of 17.65 falls within the Historic Trend Line -Fairly Valued range.
ICU Medical Inc (ICUI) has a current Price-to-Book (P/B) ratio of 1.61. Compared to its 3-year average P/B ratio of 1.64 , the current P/B ratio is approximately -1.73% higher. Relative to its 5-year average P/B ratio of 2.01, the current P/B ratio is about -20.05% higher. ICU Medical Inc (ICUI) has a Forward Free Cash Flow (FCF) yield of approximately 2.10%. Compared to its 3-year average FCF yield of 1.74%, the current FCF yield is approximately 21.24% lower. Relative to its 5-year average FCF yield of 1.99% , the current FCF yield is about 5.69% lower.
1.61
P/B
Median3y
1.64
Median5y
2.01
2.10
FCF Yield
Median3y
1.74
Median5y
1.99
Competitors Valuation Multiple
The average P/S ratio for ICUI's competitors is 5.88, providing a benchmark for relative valuation. ICU Medical Inc Corp (ICUI) exhibits a P/S ratio of 1.58, which is -73.18% above the industry average. Given its robust revenue growth of -8.85%, this premium appears unsustainable.
Performance Decomposition
1Y
3Y
5Y
Market capitalization of ICUI decreased by 8.54% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from -234.67 to -443.68.
The secondary factor is the Revenue Growth, contributed -8.85%to the performance.
Overall, the performance of ICUI in the past 1 year is driven by P/E Change. Which is more unsustainable.
People Also Watch
Frequently Asked Questions
Is ICU Medical Inc (ICUI) currently overvalued or undervalued?
ICU Medical Inc (ICUI) is now in the Undervalued zone, suggesting that its current forward PS ratio of 1.58 is considered Undervalued compared with the five-year average of -19.66. The fair price of ICU Medical Inc (ICUI) is between 217.13 to 331.34 according to relative valuation methord. Compared to the current price of 150.32 USD , ICU Medical Inc is Undervalued By 30.77% .
What is ICU Medical Inc (ICUI) fair value?
ICUI's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of ICU Medical Inc (ICUI) is between 217.13 to 331.34 according to relative valuation methord.
How does ICUI's valuation metrics compare to the industry average?
The average P/S ratio for ICUI's competitors is 5.88, providing a benchmark for relative valuation. ICU Medical Inc Corp (ICUI) exhibits a P/S ratio of 1.58, which is -73.18% above the industry average. Given its robust revenue growth of -8.85%, this premium appears unsustainable.
What is the current P/B ratio for ICU Medical Inc (ICUI) as of Jan 09 2026?
As of Jan 09 2026, ICU Medical Inc (ICUI) has a P/B ratio of 1.61. This indicates that the market values ICUI at 1.61 times its book value.
What is the current FCF Yield for ICU Medical Inc (ICUI) as of Jan 09 2026?
As of Jan 09 2026, ICU Medical Inc (ICUI) has a FCF Yield of 2.10%. This means that for every dollar of ICU Medical Inc’s market capitalization, the company generates 2.10 cents in free cash flow.
What is the current Forward P/E ratio for ICU Medical Inc (ICUI) as of Jan 09 2026?
As of Jan 09 2026, ICU Medical Inc (ICUI) has a Forward P/E ratio of 173.53. This means the market is willing to pay $173.53 for every dollar of ICU Medical Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for ICU Medical Inc (ICUI) as of Jan 09 2026?
As of Jan 09 2026, ICU Medical Inc (ICUI) has a Forward P/S ratio of 1.58. This means the market is valuing ICUI at $1.58 for every dollar of expected revenue over the next 12 months.